Welcome to our dedicated page for Amn Healthcare news (Ticker: AMN), a resource for investors and traders seeking the latest updates and insights on Amn Healthcare stock.
AMN Healthcare Services, Inc. (NYSE: AMN) is a healthcare workforce company that reports regularly on its financial performance, capital structure and workforce platforms. The AMN news stream features earnings releases, strategic announcements and updates on technology and partnership initiatives that affect its Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions segments.
Investors and industry observers can find quarterly results detailing consolidated revenue, segment performance, gross margin, operating income, and non-GAAP metrics such as adjusted EBITDA and adjusted diluted EPS. These releases also discuss trends in travel nurse staffing, allied staffing, locum tenens, interim leadership, language services and vendor management systems revenue, as well as commentary from management on market conditions and workforce demand.
AMN Healthcare’s news also covers corporate finance developments, including senior notes offerings, amendments to its revolving credit facility and related debt redemption activities. These items provide insight into how the company manages its capital structure and financial flexibility.
In addition, AMN issues news about its workforce technology and partnerships, such as the sale of its Smart Square scheduling software to symplr and the related commercial partnership that links AMN’s WorkWise workforce planning, analytics and AI capabilities with external scheduling and operational tools. The company’s Physician Solutions division also publishes reports on physician and advanced practitioner recruiting incentives, including starting salary trends and demand for medical specialties.
By following AMN Healthcare news, readers can track developments in healthcare staffing demand, the evolution of its workforce technology platforms, and the company’s strategic and financial decisions. This news page aggregates these updates in one place for convenient access.
AMN Healthcare (NYSE:AMN) has been recognized in the HRO Today Baker’s Dozen best-in-class awards for Recruitment Process Outsourcing (RPO) based on customer satisfaction. The company was rated as a leader in overall RPO, Breadth of Service, Size of Deal, and Quality of Service for healthcare and midsize company RPO. This achievement highlights AMN's commitment to optimizing recruitment processes for healthcare organizations, enabling quick hiring of quality candidates while lowering costs and enhancing patient experiences.
AMN Healthcare Services, Inc. (NYSE: AMN) has scheduled a conference call to discuss its Q3 2020 financial results on November 5, 2020, at 5:00 p.m. Eastern Time, following an earnings release expected around 4:15 p.m. that day. Investors can access the live webcast on AMN's website. The company, a leader in total talent solutions for healthcare organizations, provides a comprehensive network of healthcare professionals and various services to enhance workforce efficiency and patient outcomes.
AMN Healthcare Services, Inc. has announced the pricing of a private offering of $350 million senior unsecured notes due 2029, up from an earlier estimate of $325 million. These notes will have a 4% interest rate and will be used to redeem existing 2024 notes totaling $325 million, cover offering expenses, and repay part of its Revolving Facility borrowings. The offering is expected to close on October 20, 2020. The notes will only be available to qualified institutional buyers and non-U.S. persons, and will not be registered under the Securities Act.
AMN Healthcare Services, Inc. (NYSE: AMN) announced a private offering of $325 million in senior unsecured notes due 2029. The offering aims to redeem all of its $325 million 5.125% senior unsecured notes due 2024 and cover related fees and expenses. The 2029 Notes will be available only to qualified institutional buyers and are not registered under the Securities Act.
This strategic move is intended to enhance the company's capital structure and financial flexibility.
AMN Healthcare has appointed Rear Admiral Sylvia Trent-Adams, PhD, RN, FAAN, to its Board of Directors. Trent-Adams, a former Deputy Surgeon General, brings extensive public health experience and leadership in federal health programs. Her past roles include managing the Ryan White HIV/AIDS Program, which serves over half a million uninsured individuals. CEO Susan Salka emphasized that Trent-Adams' commitment to underserved populations will enhance AMN's service delivery. The appointment aligns with AMN's values of ethical practice and health equity.
AMN Healthcare (NYSE: AMN) has introduced an innovative service combining teletherapy for schools with video interpretation services, enabling therapy professionals to assist students and parents with limited English proficiency or hearing impairments. This initiative leverages an advanced teletherapy platform alongside medically qualified interpreters, aiming to enhance access to care and support the educational needs of disabled students. Approximately 7 million disabled students, who represent 14% of public school enrollment in the U.S., are projected to benefit from this expansion in healthcare services.
AMN Healthcare Services announced the pricing of a private offering for an additional $200 million of 4.625% Senior Notes due 2027, increasing the original amount by $50 million. The notes will be issued at 101.00% of their face value and are guaranteed by the company’s affiliates under existing credit facilities. The funds will be utilized to repay a portion of existing term loan debt and cover offering-related fees. The offering is set to close on August 13, 2020, pending customary conditions.
AMN Healthcare Services, Inc. (NYSE: AMN) announced a private offering of $150 million in 4.625% Senior Notes due 2027, under existing indentures. The proceeds will primarily be used to repay part of existing term loan debt and cover offering-related expenses. The notes will be offered to qualified institutional buyers and non-U.S. persons, complying with applicable regulations. The existing notes, initially totaling $300 million, were issued in October 2019. The offering does not constitute an offer to sell or solicit purchases in jurisdictions where it is illegal.
AMN Healthcare Services reported significant growth in Q2 2020, with revenues reaching $608.4 million, a 14% increase year-over-year, and adjusted EBITDA of $80.5 million. Travel nurse staffing surged by 41%, showcasing strong recovery despite COVID-19 disruptions. However, net income fell 23% to $22.3 million, reflecting operational costs and integration expenses from acquisitions. The company anticipates Q3 revenue to decline 10% but expects growth in technology and workforce solutions by 140%.
AMN Healthcare has moved up in the Fortune 1000 rankings, now at 939 for 2020, highlighting its growth since entering the list at 964 in 2017. With reported annual revenues reaching $2.2 billion and a market value of $2.9 billion as of December 31, 2019, the company is recognized for its comprehensive talent solutions in healthcare. Notably, it is among only 62 companies in the Fortune 1000 with women CEOs. CEO Susan Salka attributes this ascent to innovative strategies and strong partnerships with clients.